Where to Inject Wegovy in Arm: A Comprehensive Guide to Your Injection Journey

Last reviewed: July 7, 2026

Last updated: July 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The upper arm (deltoid region) is one of four recommended subcutaneous injection sites for semaglutide therapy, alongside the abdomen, thigh, and buttocks. Rotating injection locations helps reduce lipohypertrophy—the buildup of fatty tissue that can impair medication absorption—while maintaining consistent weekly dosing. Understanding arm injection anatomy and technique is essential for treatment success.

Arm Anatomy for Semaglutide Injection Safety

The deltoid muscle on the outer upper arm provides an accessible subcutaneous layer ideal for weekly GLP-1 therapy. This region sits between the shoulder and elbow, roughly one-third down from the shoulder joint, where skin thickness and fat distribution remain relatively consistent across body types. The arm avoids major blood vessels and nerves when injected correctly, making it a preferred alternative for patients who prefer not using abdominal sites.

Successful arm injection requires identifying the correct anatomical landmark: locate the top of your shoulder, then measure down about 3 inches (roughly the width of three fingers) to the middle of the outer arm. This sweet spot positions the needle in the subcutaneous tissue—the fatty layer beneath the skin but above muscle—where semaglutide achieves optimal absorption. Injecting into muscle tissue or too shallow into the dermis can cause injection-site reactions or reduce drug effectiveness.

Step-by-Step Technique for Injecting Semaglutide in Your Arm

Begin by washing your hands and gathering your pre-filled semaglutide pen, alcohol swab, and a sharps disposal container. Allow the pen to sit at room temperature for 15–30 minutes if refrigerated, as cold medication can increase discomfort and may affect injection quality. Pinch the clean injection site gently to create a small fold of skin and subcutaneous tissue, then insert the needle at a 90-degree angle (perpendicular to your arm) rather than a slant, which ensures medication reaches the subcutaneous layer.

Hold the pen steady for 3 seconds after needle insertion to allow the medication to begin dispersing, then slowly withdraw the needle and release the skin pinch. Do not rub the injection site afterward, as massage can accelerate medication absorption and cause uneven distribution. Most patients report minimal discomfort when using a relaxed arm position and avoiding rapid needle insertion; taking slow, deep breaths during injection also reduces pain perception through parasympathetic nervous system activation.

Injection Site Rotation Pattern to Prevent Lipohypertrophy

Lipohypertrophy—localized thickening and hardening of fatty tissue—occurs when the same injection area is used repeatedly without adequate spacing. Rotating among the four recommended sites (left arm, right arm, abdomen, thigh) with at least 1 inch of separation between weekly injections minimizes this risk. A practical rotation pattern involves using the right arm in week one, left arm in week two, abdomen in week three, and thigh in week four, then repeating the cycle; this spacing ensures tissue recovery while maintaining treatment consistency.

Examine your arm injection sites weekly for visible lumps, discoloration, or areas of thickened skin that may indicate developing lipohypertrophy. If you notice changes, pause arm injections for 2–4 weeks and rotate to the abdomen or thigh exclusively until the tissue appears normal. Lipohypertrophy is reversible when caught early and injection sites are rotated appropriately, but continued injection into affected areas can create permanent cosmetic changes and reduce medication absorption by up to 25–30%.

Managing Arm Injection Discomfort and Side Effects

Pain at the injection site is typically mild and brief, lasting seconds to minutes, but several strategies minimize discomfort further. Apply a topical anesthetic cream (lidocaine 4–5%) to the injection area 15 minutes before injection and allow it to fully dry, then ensure your needle is sharp and the medication is at room temperature—cold semaglutide and dull needles both increase pain significantly. Deep breathing, muscle relaxation, and distraction during injection activate pain-modulating pathways in your brain and reduce perceived discomfort by 30–40% in clinical observations.

Post-injection reactions—redness, mild swelling, or itching lasting under 24 hours—are common and typically resolve without intervention. If reactions persist beyond 48 hours, worsen progressively, or develop a warm sensation suggesting infection, contact your healthcare provider or PlexusDx support immediately. Rotating injection sites and maintaining proper injection depth will prevent most localized reactions; PlexusDx patients receive detailed injection instruction guides with their first shipment to ensure technique mastery from day one.

How PlexusDx Supports Your Semaglutide Injection Journey

PlexusDx provides compounded semaglutide injections from licensed 503A compounding pharmacies at a flat rate at $189/mo month-to-month, or from $149/mo on the 6-month plan, with pricing that remains stable regardless of dose adjustments. Every patient receives step-by-step injection technique videos, printable site rotation charts, and access to clinical support specialists who can troubleshoot injection concerns or anatomical questions. PlexusDx medications are available in all 50 states without insurance requirements, and HSA/FSA funds can be applied to reduce out-of-pocket costs.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is it safe to inject semaglutide in the arm every week?

Yes, arm injection is safe for weekly semaglutide therapy when injection sites are rotated adequately (at least 1 inch apart) and proper subcutaneous technique is followed. Arm rotation with other sites (abdomen, thigh, buttocks) across a four-week cycle prevents lipohypertrophy and maintains medication absorption efficiency throughout your treatment.

What happens if I inject semaglutide too shallow or too deep in my arm?

Injecting too shallow (into skin rather than subcutaneous fat) may cause surface irritation, bruising, or reduced medication absorption. Injecting too deep (into muscle) can trigger muscle soreness, delayed absorption, and unpredictable blood-glucose response. The 90-degree angle with a gentle pinch ensures correct depth in the subcutaneous layer.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan across all dose levels—your dose may need to go up, but your price won't. The medication comes from licensed 503A compounding pharmacies, requires no insurance, and is HSA/FSA eligible.

What should I do if my injection site becomes hardened or lumpy?

Hardening or lumpiness suggests lipohypertrophy and indicates you should stop arm injections for 2–4 weeks and rotate exclusively to abdomen or thigh sites. Early site rotation prevents progression; if lumps persist after adequate rotation and rest, contact PlexusDx clinical support to rule out infection or other complications.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Injection Wegovy
• Wegovy Injection Site
• Wegovy Injection
• Ro Wegovy

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.